<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>药融圈 | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2020-11-11T11:10:57+08:00</updated>
  <subtitle>药融圈PHARNEX汇聚数万医药大咖，得到数千家医药创业者鼎力支持，开展日常专题讲座。致力于成为“专业、前沿、权威、严谨”的医药行业资讯平台，以及项目、技术、工厂、融资、股权投资等资源整合平台。欢迎您关注药融圈，共同碰撞“药”的火花!</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>中国首款湿疹新药,辉瑞Crisaborole售价来袭！</title>
    <updated>2020-11-10T19:47:45+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-10:/s/L1tPIjrnVcxZKtR3cTjRWw</id>
    <link href="https://mp.weixin.qq.com/s/L1tPIjrnVcxZKtR3cTjRWw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>昭衍新药：在手订单17亿+，将成为第4家A+H的CRO</title>
    <updated>2020-11-10T19:47:45+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-10:/s/rWZg3YTSM_h5LzYr3NsI-w</id>
    <link href="https://mp.weixin.qq.com/s/rWZg3YTSM_h5LzYr3NsI-w" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【就在明天，成都】2020中国新药创新者大会-药物发现到临床的攀珠峰之旅</title>
    <updated>2020-11-10T19:47:45+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-10:/s/X51snH6m51iRgjuEk6726g</id>
    <link href="https://mp.weixin.qq.com/s/X51snH6m51iRgjuEk6726g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>晶泰科技：拥抱人工智能，开启药物研发快进模式</title>
    <updated>2020-11-10T19:47:45+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-10:/s/2nJSUuFPXhGQ7UW2pE6GEg</id>
    <link href="https://mp.weixin.qq.com/s/2nJSUuFPXhGQ7UW2pE6GEg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>未来已来——特应性皮炎领域深度梳理</title>
    <updated>2020-11-10T19:47:45+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-10:/s/l4Oq_1qVY9_A3p9EDuWMpQ</id>
    <link href="https://mp.weixin.qq.com/s/l4Oq_1qVY9_A3p9EDuWMpQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【每日药闻】健友股份再获阿扎胞苷ANDA，海外制剂放量可期；先导收购vernalis加速全球化..</title>
    <updated>2020-11-10T19:47:45+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-10:/s/Y0LNce-xnDDf0DbQ2hn-dA</id>
    <link href="https://mp.weixin.qq.com/s/Y0LNce-xnDDf0DbQ2hn-dA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>派克生物-一站式生命科学解决方案供应商</title>
    <updated>2020-11-10T19:47:45+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-10:/s/JFqijmT9auF2JyhDALMxDA</id>
    <link href="https://mp.weixin.qq.com/s/JFqijmT9auF2JyhDALMxDA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>格林泰科 | 一站式临床前新药研发技术服务平台</title>
    <updated>2020-11-10T19:47:45+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-10:/s/pwlOZFNS9KZAoFdj7wJavg</id>
    <link href="https://mp.weixin.qq.com/s/pwlOZFNS9KZAoFdj7wJavg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>大卖25亿美元GLP-1 ： Semaglutide获治疗NASH突破性疗法资格</title>
    <updated>2020-11-09T23:43:31+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-09:/s/cKmV1TVSmoara22KNauqwQ</id>
    <link href="https://mp.weixin.qq.com/s/cKmV1TVSmoara22KNauqwQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>当过高校教授、做过跨国药企高管，艾美菲生物范国煌博士谈全球创新</title>
    <updated>2020-11-09T23:43:31+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-09:/s/ieW4wAjXCpR8lTP-TTBbng</id>
    <link href="https://mp.weixin.qq.com/s/ieW4wAjXCpR8lTP-TTBbng" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>杭州百诚医药-集原料合成、制剂开发、质量研究、BE研究、药品注册等为一体</title>
    <updated>2020-11-09T23:43:31+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-09:/s/ck9nq8sYKriyIdFD_ZZ04Q</id>
    <link href="https://mp.weixin.qq.com/s/ck9nq8sYKriyIdFD_ZZ04Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【每日药闻】健康元吸入制剂申报符合预期，业绩稳健增长；柳药股份三季度业务加速恢复，工业板块未来可期...</title>
    <updated>2020-11-09T23:43:31+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-09:/s/0JGoesnreWxhWQsYpDod2w</id>
    <link href="https://mp.weixin.qq.com/s/0JGoesnreWxhWQsYpDod2w" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>四川康城生物-专业提供高质量临床前药物研发外包服务</title>
    <updated>2020-11-09T23:43:31+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-09:/s/QVyF41AmBA32LwA2w-wZvQ</id>
    <link href="https://mp.weixin.qq.com/s/QVyF41AmBA32LwA2w-wZvQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>振东制药盐酸二甲双胍片通过仿制药一致性评价</title>
    <updated>2020-11-09T23:43:31+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-09:/s/j0azYRMIQMN4iishC3g-cQ</id>
    <link href="https://mp.weixin.qq.com/s/j0azYRMIQMN4iishC3g-cQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【倒计时2天】2020中国新药创新者大会邀您相约成都</title>
    <updated>2020-11-09T23:43:31+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-09:/s/gMYczjlO6nV46yh3bQy_Og</id>
    <link href="https://mp.weixin.qq.com/s/gMYczjlO6nV46yh3bQy_Og" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>BMS原创氘代TYK2新药，3期银屑病临床击败阿普斯特</title>
    <updated>2020-11-08T22:10:30+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-08:/s/tszdxMLCYIdhjkPxzC54Ng</id>
    <link href="https://mp.weixin.qq.com/s/tszdxMLCYIdhjkPxzC54Ng" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>上海凌凯医药-打造全球领先医药研发、生产服务外包供应商</title>
    <updated>2020-11-08T22:10:30+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-08:/s/t605LiZmIkkg49SF0I0idA</id>
    <link href="https://mp.weixin.qq.com/s/t605LiZmIkkg49SF0I0idA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【每日药闻】丽珠集团制剂板块逐渐恢复，三季度业绩高增长；司太立X射线造影剂基本复产，艾克显碘帕醇打出首针....</title>
    <updated>2020-11-08T22:10:30+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-08:/s/LcRS-m3yEqbgkbV49AlnTg</id>
    <link href="https://mp.weixin.qq.com/s/LcRS-m3yEqbgkbV49AlnTg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>恒瑞医药卡瑞利珠再次列为拟纳入优先评审，新适应症有望获批</title>
    <updated>2020-11-08T22:10:30+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-08:/s/668YQHUgeasiDrGQAoUj7A</id>
    <link href="https://mp.weixin.qq.com/s/668YQHUgeasiDrGQAoUj7A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【免费】2020“华北地区”药物技术峰会暨仿制药一致性评价大会</title>
    <updated>2020-11-08T22:10:30+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-08:/s/3ZdhMwqtRLHuJf12zkZ4eg</id>
    <link href="https://mp.weixin.qq.com/s/3ZdhMwqtRLHuJf12zkZ4eg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>